The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
72
Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose.
Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose.
Department of Anaesthesiology, Glostrup University Hospital
Glostrup Municipality, Copenhagen, Denmark
Pain-Score (VAS) - patient standing
Pain-score messured on a Visual Analog Scale (VAS) 2 hours after adductor canal block. Patient standing. Intervention-group vs. placebo-group.
Time frame: 2 hours postoperative
Pain-score (VAS), patient at rest
ACB-group vs. placebo
Time frame: 0,1,2,4,6,8,24 hours postoperative
Pain-score (VAS), patient standing
ACB-group vs. placebo
Time frame: 1,2,4,6,8,24 hours postoperative
Pain-score (VAS), after 5 meters of walk
ACB-group vs. placebo
Time frame: 2,4,6,8,24 hours postoperative
Total Opioid-consumption
ACB-group vs. placebo-group
Time frame: 0-24 hours postoperative
Opioid-consumption, postoperative
i.v. morfin 0-2 hours postoperative tbl. morfin 2-24 hours postoperative ACB vs. placebo
Time frame: 0-2, 2-4, 4-6, 6-8, 8-24 hours postoperative
Postoperative Nausea and vomiting
Rating-scale 0-3 ACB-group vs. placebo-group
Time frame: 0-1, 1-2, 2-4, 4-6, 6-8, 8-24 hours postoperative
Postoperative ondansetron consumption
ACB-group vs. placebo-group
Time frame: In-hospital
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Sedation
Rating-scale: 0-3 ACB-group vs. placebo-group
Time frame: 0,1,2,4,6,8,24 hours postoperative